Back to News
Feb 25, 2026 4:20 PM

Earnings Breakdown: ADMA Biologics Q4

The earnings results for ADMA Biologics (NASDAQ:ADMA) for Q4 were made public on Wednesday, February 25, 2026 at 04:05 PM.

Here's a comprehensive overview of the announcement.

Earnings

ADMA Biologics beat estimated earnings by 7.5%, reporting an EPS of $0.215 versus an estimate of $0.2.

Revenue was up $21.61 million from the same period last year.

Previous Earnings Records

The company missed on ...